Treg cell lineage specific molecules, TCR/CD28 signaling, metabolism and inflammatory cytokines are factors that have been implicated in the induction of both fragile and ex-Treg cells in cancer resulting in the abolition of the highly immunosuppressive TME and successful control of tumor growth by the immune system. The gene discussed is CD28; the disease is neoplasm.